Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001470831-26-000700 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 10, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
53,000
Total Value
$855,044.46
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jul 8, 2026 | Exercise/Conversion | 12,500 | $3.79 | $47,372.50 | 157,855 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 8, 2026 | Sale | 22,757 | $28.60 | $650,895.71 | 135,098 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 8, 2026 | Sale | 4,413 | $29.82 | $131,615.96 | 130,685 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 8, 2026 | Sale | 830 | $30.31 | $25,160.29 | 129,855 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jul 8, 2026 | Exercise/Conversion | 11,592 | $0.00 | $0.00 | 58,992 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jul 8, 2026 | Exercise/Conversion | 908 | $0.00 | $0.00 | 38,836 | Direct | โ | View Details |